Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quidelortho Corp
(NQ:
QDEL
)
39.64
-0.05 (-0.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Quidelortho Corp
< Previous
1
2
3
4
5
6
7
Next >
QuidelOrtho Corporation (QDEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
February 26, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of QuidelOrtho Corporation (QDEL) on Behalf of Investors
February 22, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of QuidelOrtho Corporation (QDEL) on Behalf of Investors
February 21, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of QuidelOrtho Corporation (QDEL) on Behalf of Investors
February 21, 2024
From
Law Offices of Frank R. Cruz
Via
Business Wire
QuidelOrtho CEO Terminated: Johnson Fistel Continues Investigation
February 21, 2024
From
Johnson Fistel, LLP
Via
Business Wire
QuidelOrtho Announces Changes in Executive Leadership
February 21, 2024
From
QuidelOrtho Corporation
Via
Business Wire
Berman Tabacco Announces Investigation of QuidelOrtho Corporation (QDEL) for Potential Securities Law Violations
February 14, 2024
From
Berman Tabacco
Via
GlobeNewswire
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
February 13, 2024
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
January 23, 2024
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 22, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
December 20, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Participate in the Evercore ISI Conference
November 16, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Third Quarter 2023 Financial Results
November 01, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
October 12, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
September 21, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 28, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Second Quarter 2023 Financial Results
August 08, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
July 25, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
July 25, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Report Second Quarter 2023 Financial Results
July 18, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
May 23, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports First Quarter 2023 Financial Results
May 03, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
April 13, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
March 28, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
March 08, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
March 02, 2023
From
QuidelOrtho Corporation
Via
Business Wire
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
March 01, 2023
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Via
MarketBeat
Topics
Initial Public Offering
Exposures
COVID-19
Product Safety
Securities Market
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
February 15, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
January 06, 2023
From
QuidelOrtho Corporation
Via
Business Wire
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
December 28, 2022
From
QuidelOrtho Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.